Profile
Stefan Proniuk worked as a Scientist at CIMA Labs, Inc. from 2000 to 2002.
He then worked as a Senior Manager-Pharmaceutical Technologies at Neurocrine Biosciences, Inc. from 2002 to 2008.
From 2008 to 2017, he served as the Chief Development Officer at Arno Therapeutics, Inc. Dr. Proniuk holds an MBA from San Diego State University and a doctorate from the University of Arizona.
Former positions of Stefan Proniuk
| Companies | Position | End |
|---|---|---|
| ARNO THERAPEUTICS, INC. | Corporate Officer/Principal | 31/03/2017 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 31/12/2007 |
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Corporate Officer/Principal | 31/12/2001 |
Training of Stefan Proniuk
| University of Arizona | Doctorate Degree |
| San Diego State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARNO THERAPEUTICS, INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
- Stock Market
- Insiders
- Stefan Proniuk
